Showing posts with label pharmtech talk. Show all posts
Showing posts with label pharmtech talk. Show all posts

Monday, June 29, 2009

Could drug delivery methods prevent prescription abuse?

In an article at PharmTech, they look at how changing drug delivery methods could prevent prescription drug abuse. While changing the drug delivery method could stop abusers from taking the prescriptions, it would allow the doses to be available to those who still needed the drug therapies.

Erik Greb looks at how one company appears to be on the right track for this: Atlantic Pharmaceuticals (Atlanta, GA) wants to use its Smart/Script oral delivery technology to deter oxycodone abuse. Loading a drug into the Smart/Script technology renders it noncrushable and nonextractable in common injectable solutions, according to the company’s website. Smart/Script protects the drug until it reaches the gastrointestinal system, where it is released.

Do you think companies should work on changing drug delivery methods to prevent drug overdose?

If you'd like to network with other professionals in the drug delivery field, join our LinkedIn group!


Share this article with your social network, just click below to share now!


Friday, March 6, 2009

Spelling Out a Drug’s Risks and Benefits

Patricia Van Arnum of PharmTech Talk adds her thoughts on the results of a study by Steven Woloshin and Lisa Schwartz in which the researchers showed that a drug-fact box improved US consumers' knowledge of prescription drugs’ benefits and side effects. Van Arnum thinks that a better solution (than print advertising) would be to require physicians to provide patients with drug-fact boxes at the time of dispensing prescription drugs, so that a patient could review the information before deciding to take a drug and filling a prescription. She thinks that this practice would allow patients to easily review drug information and to discuss any concerns with their doctors and to give them access to information before reviewing product insert information after a prescription is filled, which is typically the first time that a patient may review drug information in any detail. So what do you think? Should drug information be solely on print, solely in the doc's office or both?


Share this article with your social network, just click below to share now!